Literature DB >> 15557520

Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes.

A Lladó1, P Mannucci, A F Carpentier, S Paris, Y Blanco, A Saiz, J Y Delattre, F Graus.   

Abstract

The long-term evolution of Hu antibody (Hu-Ab) titers in patients with paraneoplastic neurologic syndromes (PNSs) is not known. Described is the evolution of Hu-Ab titers in 35 patients with PNS with a median follow-up of 32 months (range 6 to 108 months). No correlation was observed between Hu-Ab titers and neurologic outcome, tumor evolution, or type of treatment. Serial Hu-Ab determinations are not useful for monitoring the clinical outcome of patients with PNS.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15557520     DOI： 10.1212/01.wnl.0000144340.03364.bf

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  11 in total

1.  Clinical and immunological diversity of limbic encephalitis: a model for paraneoplastic neurologic disorders.

Authors:  Josep Dalmau; Luis Bataller
Journal:  Hematol Oncol Clin North Am       Date:  2006-12       Impact factor: 3.722

2.  Isolated paraneoplastic optic neuropathy associated with small-cell lung cancer and anti-CV2 antibodies.

Authors:  Adrián Arés-Luque; L A García-Tuñón; A Saiz; B C Cabezas; L E Hernández-Echebarría; M Franco; A Toribio; J Tejada; F Graus
Journal:  J Neurol       Date:  2007-04-02       Impact factor: 4.849

Review 3.  [Antibody-associated diseases of the gray matter of the CNS: diagnosis and treatment].

Authors:  C G Bien
Journal:  Nervenarzt       Date:  2011-08       Impact factor: 1.214

Review 4.  Autoimmune epilepsies.

Authors:  Christian G Bien; Jan Bauer
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 5.  Autonomic nervous system and cancer.

Authors:  Marta Simó; Xavier Navarro; Victor J Yuste; Jordi Bruna
Journal:  Clin Auton Res       Date:  2018-03-28       Impact factor: 4.435

6.  Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates.

Authors:  Beau M Ances; Roberta Vitaliani; Robert A Taylor; David S Liebeskind; Alfredo Voloschin; David J Houghton; Steven L Galetta; Marc Dichter; Abass Alavi; Myrna R Rosenfeld; Josep Dalmau
Journal:  Brain       Date:  2005-05-11       Impact factor: 13.501

Review 7.  Encephalitis and epilepsy.

Authors:  Jan Bauer; Christian G Bien
Journal:  Semin Immunopathol       Date:  2009-09-11       Impact factor: 9.623

8.  Long-lasting remission after rituximab treatment in a case of anti-Hu-associated sensory neuronopathy and gastric pseudoobstruction.

Authors:  Francisco Coret; Isabel Bosca; Loren Fratalia; Jaume Perez-Griera; Ana Pascual; Bonaventura Casanova
Journal:  J Neurooncol       Date:  2009-01-13       Impact factor: 4.130

9.  [Pathophysiology of antibody-associated diseases of the central nervous system].

Authors:  C G Bien; J Bauer
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

10.  Validation of Predictive Models for Autoimmune Encephalitis-Related Antibodies to Cell-Surface Proteins Expressed in Neurons: A Retrospective Study Based in a Hospital.

Authors:  Siqi Ding; Jiaoni Gong; Jiahe Lin; Yi Wang; Yingjie Hua; Xueying Li; Yanru Du; Niange Xia; Zhenguo Zhu; Xinshi Wang; Rongyuan Zheng; Huiqin Xu
Journal:  Front Neurol       Date:  2021-05-14       Impact factor: 4.003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.